Tufts CTSI fosters innovative research across the translational spectrum. Publications that cite us include:
- High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011 Jul;17(7):1012-7
- Training and career development for comparative effectiveness research workforce development: CTSA Consortium Strategic Goal Committee on comparative effectiveness research workgroup on workforce development. Clinical and translational science 2010 Oct;3(5):258-62
- Paraoxonase 1 polymorphisms and ischemic stroke risk: A systematic review and meta-analysis. Genetics in medicine : official journal of the American College of Medical Genetics 2010 Oct;12(10):606-15
- Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach. Journal of the American College of Cardiology 2010 Jul 27;56(5):392-406
- Aggregating and disaggregating patients in clinical trials and their subgroup analyses. Annals of internal medicine 2010 Jul 6;153(1):51-2
- Development of a combined database for meta-epidemiological research. Research synthesis methods 2010 Jul;1(3-4):212-25
- Meta-research: The art of getting it wrong. Research synthesis methods 2010 Jul;1(3-4):169-84
- Fluorine-18-fluorodeoxyglucose positron emission tomography in response assessment before high-dose chemotherapy for lymphoma: a systematic review and meta-analysis. The oncologist 2010;15(7):750-9
- Tufts CTSI: comparative effectiveness research as a conceptual framework for a focus on impact. Clinical and translational science 2010 Apr;3(2):56-8
- White paper on CTSA consortium role in facilitating comparative effectiveness research: September 23, 2009 CTSA consortium strategic goal committee on comparative effectiveness research. Clinical and translational science 2010 Feb;3(1):29-37
- Critical interpretation of Cochran's Q test depends on power and prior assumptions about heterogeneity. Research synthesis methods 2010 Apr;1(2):149-61
- Therapeutic innovations, diminishing returns, and control rate preservation. JAMA 2009 Nov 25;302(20):2254-6
- Industry influence on comparative-effectiveness research funded through health care reform. The New England journal of medicine 2009 Dec 31;361(27):2595-7